| Not Yet Recruiting | Intratumoral N17350 in Advanced Solid Tumors NCT07339176 | Onchilles Pharma Inc | Phase 1 / Phase 2 |
| Recruiting | Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis NCT07491536 | University of Pavia | N/A |
| Not Yet Recruiting | Access to Care Pilot for ED-Presenting Head and Neck Cancer Patients (ENRICH-HNC) NCT07225725 | University of Tennessee | N/A |
| Not Yet Recruiting | Decitabine and Nivolumab in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Nec NCT07216833 | Kyunghee Burkitt, DO, PhD | Phase 1 |
| Recruiting | Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC NCT06912087 | University of Chicago | Phase 1 |
| Completed | Ozone Therapy for the Treatment of Oral Mucositis in Patients Undergoing Radio and Chemotherapy in the Head an NCT07247799 | Andrea Scribante | — |
| Completed | Effectiveness of Manual Acupuncture for Head and Neck Cancer Patients Undergoing Chemoradiation NCT07044414 | Indonesia University | N/A |
| Recruiting | DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment NCT07158164 | Rutgers, The State University of New Jersey | Phase 4 |
| Recruiting | Head and Neck Cancer Study Project in the Geriatric Population NCT06998069 | Brown University | Phase 3 |
| Completed | Laser vs Ozone Therapy for Oral Mucositis in Cancer Patients NCT07069153 | University of Pavia | N/A |
| Recruiting | Heavy Strength Training in Head and Neck Cancer Survivors NCT06289049 | University of Alberta | Phase 2 |
| Recruiting | Upfront Surgery Vs Induction Chemotherapy Followed By Surgery In Oral Cancers: NCT06737822 | All India Institute of Medical Sciences, Jodhpur | Phase 3 |
| Enrolling By Invitation | Post-Operative Antibiotic Efficacy in Clean Contaminated Head and Neck Surgery: A Randomized Controlled Trial NCT06672471 | Shaukat Khanum Memorial Cancer Hospital & Research Centre | N/A |
| Not Yet Recruiting | Evaluation of Two Methods of Administration of Photobiomodulation in the Context of the Prevention and Treatme NCT06458517 | Institut de cancérologie Strasbourg Europe | N/A |
| Withdrawn | Simultaneous Care in Recurrent and/or Metastatic Head and Neck Cancer: the SupCare Study NCT06347185 | European Organisation for Research and Treatment of Cancer - EORTC | N/A |
| Recruiting | NIDCD Otolaryngology Clinical Protocol Biospecimen Bank NCT06303180 | National Institute on Deafness and Other Communication Disorders (NIDCD) | — |
| Recruiting | Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal C NCT06365866 | Taipei Veterans General Hospital, Taiwan | N/A |
| Recruiting | Feasibility Testing a Decision-support Intervention for Clinical Trials NCT06291610 | University of Aarhus | N/A |
| Not Yet Recruiting | ctDNA and MRI Parameters in Head and Neck Cancer NCT06215612 | Franziska Eckert | N/A |
| Active Not Recruiting | A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 G NCT06237881 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Recruiting | Adaptive Radiotherapy in Head and Neck Tumor Patients NCT06216171 | University Hospital, Essen | N/A |
| Terminated | Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer NCT06110195 | University of Chicago | Phase 1 |
| Completed | The Impact of Dental Health on Complications During and Following Radiotherapy in the Head and Neck Region. NCT06840639 | Lund University Hospital | — |
| Active Not Recruiting | A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 NCT06003231 | Seagen, a wholly owned subsidiary of Pfizer | Phase 2 |
| Recruiting | Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors NCT05483400 | University Medical Center Groningen | Phase 2 |
| Terminated | TransCon (TC) TLR7/8 Agonist, TC IL-2 β/γ, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous NCT05980598 | Ascendis Pharma A/S | Phase 2 |
| Active Not Recruiting | Stereotactic Radiotherapy for Sinonasal Malignancy NCT06617910 | Taichung Veterans General Hospital | — |
| Recruiting | The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads NCT05811936 | Medical University of South Carolina | N/A |
| Withdrawn | Online Peri-operative Education Program for Patients Undergoing Major Head & Neck Surgery NCT05954676 | Washington University School of Medicine | N/A |
| Recruiting | HTL0039732 in Participants With Advanced Solid Tumours NCT05944237 | Cancer Research UK | Phase 1 / Phase 2 |
| Active Not Recruiting | ENHANCE - Evaluating the Implementation of Head and Neck Cancer E-health NCT05785247 | Guy's and St Thomas' NHS Foundation Trust | — |
| Completed | 3D Modeling of the Cervico-facial Region and Cranial Nerve Tractography: IMAG 2 ORL Project NCT05763615 | Assistance Publique - Hôpitaux de Paris | N/A |
| Recruiting | Arabic PRO Measures for Head and Neck Cancer Radiotherapy. NCT06662929 | King Saud University | — |
| Unknown | Evaluating Chinese Medicine Oral Rinse for Irradiated Oral Mucositis in Head & Neck Cancer Patients NCT05664906 | Chinese University of Hong Kong | Phase 1 / Phase 2 |
| Recruiting | Preventive Physical Activity Intervention in Head and Neck Cancer NCT05432297 | Sahlgrenska University Hospital | N/A |
| Recruiting | Radiation Field, Dose and Fractionation Related to Mandibular Complications NCT05412849 | Lund University Hospital | — |
| Completed | The Effect of Active Nutritional Support On Quality Of Life In Patients With Head And Neck Cancer Receiving Ra NCT06477341 | Assiut University | N/A |
| Recruiting | First in Human Study of AZD9592 in Solid Tumors NCT05647122 | AstraZeneca | Phase 1 |
| Completed | Remote Rapid Onsite Evaluation (ROSE) for Head and Neck Fine Needle Aspirations (FNA) NCT05962944 | Royal Cornwall Hospitals Trust | — |
| Suspended | A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer NCT05420948 | University of Chicago | Phase 2 |
| Completed | Photobiomodulation Therapy in Patients With Head and Neck Cancer Post-Radiotherapy NCT05614843 | Universidad de Granada | N/A |
| Recruiting | A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer NCT05544136 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Recruiting | Photobiomodulation Therapy Plus M-health in Head and Neck Cancer Patients: LAXER Study NCT05106608 | Universidad de Granada | N/A |
| Unknown | Accuracy and Safety of Coplanar Template Assistance for Head and Neck Biopsies. NCT05396183 | Peking University Third Hospital | — |
| Unknown | Evaluation the Effects of Herbal Gargle for Chemoradiotherapy-induced Oral Mucositis of Head & Neck Cancer, a NCT05341206 | Chang Gung Memorial Hospital | Phase 2 |
| Unknown | Prospective Evaluation of ENDOSWIR Device Versus Pathology for Squamous Cell Carcinoma of Upper Aerodigestive NCT05318872 | University Hospital, Grenoble | — |
| Active Not Recruiting | Factors Sustaining Tobacco Abstinence in Cancer Patients Treated With Radio-chemotherapy or Radiotherapy NCT06910566 | Centre Oscar Lambret | — |
| Active Not Recruiting | Collection of Head Images During Radiotherapy NCT05218824 | University of Sydney | — |
| Unknown | Prehabilitation and Recovery After Head and Neck Cancer Surgery NCT04598087 | University of Calgary | N/A |
| Recruiting | Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN NCT05260671 | Eye & ENT Hospital of Fudan University | Phase 2 |
| Completed | Radiation Therapy Plan Quality Improvement Using Ideal Theoretical Isodose Distribution NCT04782726 | The University of Texas Health Science Center at San Antonio | N/A |
| Completed | Assessing Benefits of Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands Duri NCT05022667 | University of Michigan | N/A |
| Withdrawn | Ideal Drainage Output of Post-operative Neck Suction Drain NCT03971760 | Centre hospitalier de l'Université de Montréal (CHUM) | N/A |
| Active Not Recruiting | The SWOAR Trial Sparing of Swallowing and Aspiration Related Organs at Risk & Submandibular Gland With Intensi NCT05187091 | All India Institute of Medical Sciences | Phase 3 |
| Unknown | Evaluation of a Cosmetic Product to Preserve Skin Conditions When Using Anti-EGFR Cancer Therapies NCT04878692 | Hospices Civils de Lyon | N/A |
| Completed | Exercise Prehabilitation in Patients With Head and Neck Squamous-cell Carcinoma: The FIT4TREAT Trial NCT05418842 | Associacao de Investigacao de Cuidados de Suporte em Oncologia | N/A |
| Terminated | A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic NCT04644315 | Hoffmann-La Roche | Phase 2 |
| Active Not Recruiting | Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy NCT05308732 | Instituto Nacional de Cancer, Brazil | Phase 1 |
| Completed | The Registry of Oncology Outcomes Associated With Testing and Treatment NCT04028479 | Taproot Health | — |
| Terminated | Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck Cancer NCT04634825 | MacroGenics | Phase 2 |
| Recruiting | The EMINENCE Study - PET/MR Imaging of Head Neck Cancer NCT04612075 | Norwegian University of Science and Technology | — |
| Unknown | External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patien NCT04697446 | Blueprint Medicines Corporation | — |
| Withdrawn | Prospective Analysis of Effect of Collagen Wrap Conduit on Radial and Ulnar Nerve Function Following Radial/Ul NCT03875833 | The University of Texas Health Science Center, Houston | N/A |
| Unknown | A Study of SBRT for Squamous Cell Carcinoma of the Head and Neck NCT04435938 | McMaster University | Phase 2 |
| Completed | Peroperative Assessment of Malignancies of the Head and Neck Using High-resolution 18F-FDG-PET/CT NCT05068687 | University Hospital, Ghent | N/A |
| Terminated | A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer NCT04222972 | Hoffmann-La Roche | Phase 3 |
| Completed | Bevonescein to Highlight Nerves in Patients Undergoing Head & Neck Surgery NCT04420689 | Alume Biosciences, Inc. | Phase 1 / Phase 2 |
| Completed | Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and NCT04247282 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Unknown | A Study of Concomitant Camrelizumab With Chemoradiation for Locally Advanced Head and Neck Cancer NCT04405154 | West China Hospital | Phase 2 |
| Recruiting | Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven NCT04429542 | Bicara Therapeutics | Phase 1 |
| Completed | Anabolic Effects of Intraoperative Feeding in Reconstruction Surgery NCT04266015 | E-DA Hospital | N/A |
| Completed | Epigenetic Changes in Head and Neck Cancer NCT04260074 | Aalborg University Hospital | — |
| Completed | The Effect of Curcumin for Treatment of Cancer Anorexia-Cachexia Syndrome in Patients With Stage III-IV of Hea NCT04208334 | Phramongkutklao College of Medicine and Hospital | Phase 2 |
| Withdrawn | Regional Anesthesia Block in Fibula Free Flap Reconstruction NCT03906838 | University of Florida | EARLY_Phase 1 |
| Completed | HFHS-1801-A Pilot Study of Immunotherapy As Consolidation Therapy for Patients with Recurrent Head and Neck Ca NCT04188951 | Henry Ford Health System | EARLY_Phase 1 |
| Unknown | The Diagnostic Value of PET/MRI in Head and Neck Cancer NCT04117139 | Odense University Hospital | N/A |
| Unknown | DAHANCA 37. Re-irradiation With Proton Radiotherapy NCT03981068 | Danish Head and Neck Cancer Group | N/A |
| Unknown | Second-Line Chemotherapy Combined With Endostatin for Recurrent/Metastatic HN Epithelial Tumors NCT03989830 | Sun Yan | Phase 2 |
| Terminated | Acute and Long-term Impact of Cancer Treatment on Head and Neck Cancer Patients: FIT4TREATMENT NCT04996147 | Associacao de Investigacao de Cuidados de Suporte em Oncologia | — |
| Recruiting | The Effects on Auditory Function of RADiotherapy and Chemotherapy Treatments for Head and Neck Tumours (EARAD) NCT03914378 | University of Manchester | — |
| Unknown | Atezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and NCT03818061 | Centre Leon Berard | Phase 2 |
| Unknown | Safety,Tolerability,and Efficacy of VCN-01 With Durvalumab in R/M Head and Neck Squamous Cell Carcinoma NCT03799744 | Institut Català d'Oncologia | Phase 1 |
| Active Not Recruiting | Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma NCT04124198 | Christian von Buchwald | N/A |
| Recruiting | The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study NCT04075305 | UMC Utrecht | — |
| Completed | Afatinib and Pembrolizumab for Head and Neck Squamous Cell Carcinoma (ALPHA Study) NCT03695510 | National Taiwan University Hospital | Phase 2 |
| Terminated | This Study Tests How BI 754111 is Distributed in Patients With Advanced Non-small Cell Lung Cancer or Patients NCT03780725 | Boehringer Ingelheim | Phase 1 |
| Unknown | Head and Neck Cancer in Children: A Retrospective Study NCT02557048 | Assiut University | — |
| Completed | Rehabilitation Planning Consult Phase II Trial NCT03672799 | University Health Network, Toronto | N/A |
| Terminated | Unilateral Neck Radiotherapy in Head and Neck Cancer NCT03622164 | AHS Cancer Control Alberta | N/A |
| Active Not Recruiting | Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Adva NCT03765918 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction NCT03549494 | Catalysis SL | Phase 2 |
| Active Not Recruiting | Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell NCT03691714 | Trisha Wise-Draper | Phase 2 |
| Completed | H&N Cancer; Survivorship and Late Effects NCT04758026 | Oslo University Hospital | — |
| Unknown | A Prospective Randomized Trial of Capecitabine Treatment in Patients With HNSCC NCT03678649 | Zhejiang Cancer Hospital | Phase 2 |
| Terminated | EMST and Swallowing in Long-Term Survivors of HNCA NCT03975465 | University of Wisconsin, Milwaukee | N/A |
| Terminated | Study of MK-1697 in Participants With Advanced Solid Tumors (MK-1697-001) NCT03515824 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Moderate Whole Body Hyperthermia for Patients Undergoing Re-irradiation for Head and Neck Cancer -Influence on NCT03547388 | Charite University, Berlin, Germany | Phase 1 |
| Withdrawn | Intraoperative Imaging of a PET Positive Lymph Node(s) Using 18FDG and a Dual-Mode, Hand-Held Intraoperative I NCT03561324 | University of Arkansas | N/A |
| Completed | Needs Assessment Tool Integrated in Clinical Practice of Head and Neck Cancer Rehabilitation NCT03443258 | Rigshospitalet, Denmark | N/A |
| Completed | Customized Registry Tool for Tracking Adherence to Clinical Guidelines for Head and Neck Cancers NCT03546322 | University of California, San Francisco | — |
| Recruiting | Biospecimen Procurement for Head and Neck Disorders NCT03429036 | National Cancer Institute (NCI) | — |
| Unknown | Radiotherapy Treatments for Neoplasms in the Head and Neck Region NCT06335342 | European Institute of Oncology | — |
| Completed | STEREO-POSTOP 01 (PostOperative Hypofractionated Stereotactic Body Radiotherapy ) - GORTEC 2017-03 NCT03401840 | Centre Jean Perrin | N/A |
| Completed | A Pilot Study to Evaluate the Feasibility and Potential Effectiveness of the Flexitouch System Head and Neck T NCT03332160 | Tactile Medical | N/A |
| Unknown | Durvalumab, Cetuximab and Radiotherapy in Head Neck Cancer NCT03051906 | Azienda Ospedaliero-Universitaria Careggi | Phase 1 / Phase 2 |
| Completed | Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With NCT03225157 | National Institute on Deafness and Other Communication Disorders (NIDCD) | — |
| Unknown | A Biomarker-driven, Open Label, Single Arm, Multicentre Phase II Study of Abemaciclib in Patients With Recurre NCT03356587 | Seoul National University Hospital | Phase 2 |
| Terminated | CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physicia NCT02900248 | CureOne | — |
| Completed | Nurse-led Exercise Improves Shoulder Pain, Shoulder Disability, and Quality of Life in Head and Neck Cancer NCT05269342 | YU LONG HONG | N/A |
| Terminated | PET/MRI to Enhance Precision Guidance in Head and Neck Radiation Treatment Planning NCT03286972 | University of Wisconsin, Madison | — |
| Completed | Korean Cancer Study Group: Translational bIomarker Driven UMbrella Project for Head and Neck (TRIUMPH), Esopha NCT03292250 | Seoul National University Hospital | Phase 2 |
| Completed | Phase II Study of Durvalumab(MEDI4736) + Tremelimumab in Pulmonary Sarcomatoid Carcinoma NCT06446570 | Seoul National University Hospital | Phase 2 |
| Terminated | EPR Tumor Oximetry With CE India Ink NCT03321903 | Philip Schaner | — |
| Recruiting | EMST in Patients Undergoing CRT for HNCA NCT03916809 | University of Wisconsin, Milwaukee | N/A |
| Completed | A Study of AK-01 (LY3295668) in Solid Tumors NCT03092934 | Eli Lilly and Company | Phase 1 / Phase 2 |
| Completed | Radiotherapy Related Skin Toxicity: Mepitel® vs. Standard Care in Patients With Locally Advanced Head-and-Neck NCT03047174 | University Hospital Schleswig-Holstein | N/A |
| Terminated | To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer NCT03020823 | SynCore Biotechnology Co., Ltd. | Phase 2 |
| Unknown | Effects of Nutritional Counseling on Nutritional Status and Quality of Life of Head and Neck Cancer Patients NCT03114202 | University of Sao Paulo General Hospital | N/A |
| Completed | Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and NCT03040999 | Merck Sharp & Dohme LLC | Phase 3 |
| Unknown | Exercise After Radiation for Head & Neck Cancer NCT04013178 | University of Calgary | N/A |
| Completed | Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinom NCT03082534 | University of California, San Diego | Phase 2 |
| Completed | Outpatient Percutaneous Radiologic Gastrostomy in Patients With Head and Neck Tumors NCT03252509 | Instituto Nacional de Cancer, Brazil | N/A |
| Completed | Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Can NCT03037385 | Hoffmann-La Roche | Phase 1 / Phase 2 |
| Unknown | Gastric Pull up Versus Free Flap Reconstruction for Laryngo-pharyngeal Defects NCT03171558 | University of British Columbia | N/A |
| Withdrawn | Trial to Determine Optimal Phase II Dose of the Oral Dual CAIX Inhibitor/ Radiosensitizer NCT02216669 | Maastricht Radiation Oncology | Phase 1 |
| Completed | ImmunoModulation by the Combination of Ipilimumab and Nivolumab Neoadjuvant to Surgery In Advanced or Recurren NCT03003637 | The Netherlands Cancer Institute | Phase 1 / Phase 2 |
| Unknown | Cell-free Tumor DNA in Head and Neck Cancer Patients NCT03942380 | Christian von Buchwald | N/A |
| Completed | Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck Disse NCT02918955 | Insel Gruppe AG, University Hospital Bern | Phase 3 |
| Unknown | Apatinib for Advanced Non-squamous Head and Neck Cancer NCT02989259 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Completed | P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC NCT03077243 | UNC Lineberger Comprehensive Cancer Center | Phase 2 |
| Unknown | uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer NCT02960724 | Rigshospitalet, Denmark | Phase 2 |
| Completed | Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema NCT02946021 | Tactile Medical | Phase 1 / Phase 2 |
| Unknown | The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer NCT02943252 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Terminated | Feasibility of Holmium-166 Micro Brachytherapy in Head and Neck Tumors NCT02975739 | UMC Utrecht | N/A |
| Completed | Pharmacotherapy Personalization of Cancer Patients NCT04866498 | Poznan University of Medical Sciences | — |
| Completed | Uniform FDG-PET Guided Gradient Dose Prescription to Reduce Late Radiation Toxicity NCT02442375 | Radboud University Medical Center | Phase 3 |
| Terminated | Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer NCT02817113 | Orient Europharma Co., Ltd. | Phase 1 |
| Completed | Therapeutic Resistance Group Exercise Training for Head & Neck Cancer Survivors NCT02647021 | University of Alberta | N/A |
| Completed | A Study of Prexasertib (LY2606368) With Chemotherapy and Radiation in Participants With Head and Neck Cancer NCT02555644 | Eli Lilly and Company | Phase 1 |
| Terminated | Benefits of MPACT in Locally Advanced Head and Neck Cancer Patients Undergoing Chemoradiotherapy NCT02485470 | University of Michigan Rogel Cancer Center | Phase 2 |
| Completed | Frequency of Xerostomia and Their Management in Upper Aerodigestive Tract Cancer Patients After the End of Rad NCT02857413 | Centre Hospitalier Universitaire de Besancon | — |
| Completed | Development and Evaluation of Rehabilitation Consult for Survivors of Head and Neck Cancer NCT02836769 | Sunnybrook Health Sciences Centre | N/A |
| Unknown | Oncogeriatric Intervention and Follow-up at Home NCT02837679 | Aarhus University Hospital | N/A |
| Terminated | Patritumab With Cetuximab and a Platinum Agent for Squamous Cell Carcinoma (Cancer) of the Head and Neck (SCCH NCT02633800 | Daiichi Sankyo | Phase 2 |
| Completed | Study of Monalizumab and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Hea NCT02643550 | Innate Pharma | Phase 1 / Phase 2 |
| Active Not Recruiting | Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (T NCT02568267 | Hoffmann-La Roche | Phase 2 |
| Active Not Recruiting | Nutrition and Inflammation in Patients With Head and Neck Cancer NCT03343236 | Uppsala University | — |
| Withdrawn | ROCOCO - Adaptive IMRT Versus IMPT in Head and Neck Cancer NCT02908386 | Maastricht Radiation Oncology | — |
| Terminated | Comparing Two Palliative Schemes of Radiotherapy for Head and Neck Cancer NCT02421458 | The Netherlands Cancer Institute | N/A |
| Completed | Remote Ischemic Preconditioning in Head and Neck Cancer Reconstruction - A Randomized Controlled Trial NCT02548377 | Aarhus University Hospital Skejby | N/A |
| Terminated | Progressive Resistance Training in Head and Neck Cancer Patients During Concomitant Chemoradiotherapy NCT02557529 | Herlev Hospital | N/A |
| Terminated | Multi-Modality Imaging for Head & Neck Cancer Free Flap Design Assessment NCT02629029 | University Health Network, Toronto | N/A |
| Completed | The Impact of Pentoxifylline and Vitamin E on Radiotherapy-induced Toxicity in Head & Neck Cancer Patients NCT02397486 | Ain Shams University | Phase 2 |
| Completed | Sentinel Lymph Node Mapping of Oral Cancer Using Near-Infrared Fluorescence Imaging NCT02478138 | University Health Network, Toronto | N/A |
| Completed | Rehabilitation for Head and Neck Cancer NCT02439892 | Norwegian University of Science and Technology | N/A |
| Completed | Prospective, Observational, Real-world Oral Malignant Tumors Study NCT02395367 | Beijing Stomatological Hospital, Capital Medical University | — |
| Completed | Image-guided Cryoablation of Head, Neck and Spine Tumors NCT02085941 | Dana-Farber Cancer Institute | N/A |
| Unknown | Total Body Composition in Detection of Nutrition Depletion in Head and Neck Patients NCT02854735 | Chang Gung Memorial Hospital | — |
| Terminated | Endoscopic Injection of Mitomycin C for the Treatment of Pharyngoesophageal Stenosis NCT03540953 | Fauze Maluf Filho | N/A |
| Completed | Irreversible Electroporation(IRE) For Unresectable Head and Neck Neoplasms NCT02335112 | Fuda Cancer Hospital, Guangzhou | N/A |
| Unknown | Efficacy of Smoking Cessation Intervention for Head and Neck Cancer Patients NCT03786172 | Saint-Joseph University | N/A |
| Unknown | THE USE OF N-ACETYLCYSTEINE ATTENUATING CISPLATIN-INDUCED TOXICITIES BY OXIDATIVE STRESS NCT02241876 | University of Campinas, Brazil | Phase 4 |
| Unknown | Recombinant Human Endostatin Adenovirus Combined With Chemotherapy for Advanced Head and Neck Malignant Tumors NCT02283489 | Renmiao Zhang | Phase 2 |
| Unknown | Olaparib and Radiotherapy in Head and Neck Cancer NCT02229656 | The Netherlands Cancer Institute | Phase 1 |
| Completed | Early Detection of Tumors of the Digestive Tract by Confocal Endomicroscopy NCT02284802 | Fauze Maluf Filho | N/A |
| Completed | Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Ne NCT02324335 | Innovation Pharmaceuticals, Inc. | Phase 2 |
| Completed | De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up Study NCT02281955 | UNC Lineberger Comprehensive Cancer Center | Phase 2 |
| Completed | The Safety and Efficacy Test of Nutri-PEITC Jelly in Head and Neck Cancer Patients NCT03034603 | Dental Innovation Foundation Under Royal Patronage | N/A |
| Completed | Smoking Cessation in Head and Neck Cancer Patients Receiving Curative Radiation Therapy NCT02251730 | National Taiwan University Hospital | Phase 2 |
| Terminated | LUX-Head & Neck 4: Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer NCT02131155 | Boehringer Ingelheim | Phase 3 |
| Completed | A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers NCT02188563 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | N/A |
| Terminated | Cetuximab Compared to Mitomycin-C and 5-Fluorouracil for Locally Advanced Squamous Cell Carcinomas of the Head NCT02015650 | Medical University Innsbruck | Phase 4 |
| Completed | LigaSure Small Jaw® Versus Conventional Neck Dissection in Head and Neck Cancer Patients NCT02597582 | Taichung Veterans General Hospital | Phase 4 |
| Completed | Leg Function and ADL After ALT Reconstruction for Head and Neck Cancer NCT02332161 | University of Chicago | — |
| Completed | Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer NCT02107235 | Traws Pharma, Inc. | Phase 1 |
| Terminated | Ketogenic Diet Phase 1 for Head & Neck Cancer NCT01975766 | Bryan Allen | N/A |
| Terminated | Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma NCT02045186 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Completed | Study to Evaluate the Natural History of Head and Neck Cancer Precursors in Taiwan NCT02017288 | National Cancer Institute (NCI) | — |
| Unknown | A Trial Comparing Two Modalities of Prophylactic Nutritional Support During Treatment for Head and Neck Cancer NCT01985438 | Shaukat Khanum Memorial Cancer Hospital & Research Centre | N/A |
| Completed | Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors NCT01639911 | University of Illinois at Chicago | Phase 1 |
| Completed | Phonosurgical Augmentation After Laser Resection of Early Glottic Carcinoma NCT04525066 | Ayhman Al Afif | Phase 2 |
| Completed | Engagement of Patients With Advanced Cancer NCT02966509 | Stanford University | N/A |
| Completed | LUX-Head&Neck 3: Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic Head NCT01856478 | Boehringer Ingelheim | Phase 3 |
| Unknown | E10A for the Treatment of Squamous Cell Carcinoma of the Head and Neck NCT02630264 | Guangzhou Double Bioproducts Co., Ltd | Phase 3 |
| Unknown | After Induction Chemotherapy of DP Plus DDP Concurrent Radiotherapy With and Without Bevacizumab Study NCT02047487 | Chinese PLA General Hospital | — |
| Completed | Impact of Fixed Dentures in Head and Neck Cancer (IMFDHAC) NCT03753932 | Region Jönköping County | N/A |
| Completed | Comparison of Two Immunomodulatory Formulas on the Number of Postoperative Infections in Head & Neck Cancer Pa NCT02622880 | Instituto de Investigación Hospital Universitario La Paz | Phase 4 |
| Completed | Activity and Safety Study of BKM120 in Monotherapy in Patient With Metastatic Head and Neck Cancer Recurrent o NCT01737450 | Centre Leon Berard | Phase 2 |
| Completed | The Translational Research Image-Guided Operating Room (TRIGORA): Intraoperative 3D Imaging for Head & Neck Su NCT03345719 | University Health Network, Toronto | — |
| Completed | Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer NCT01566435 | Washington University School of Medicine | Phase 2 |
| Completed | The Efficacy of Mouth Exercise in Oral Cancer Patients After Receiving Surgery NCT05227807 | National Taipei University of Nursing and Health Sciences | N/A |
| Withdrawn | Evaluation of Treatment Related Toxicity After Radiotherapy for Head and Neck Cancer NCT01621048 | Universitaire Ziekenhuizen KU Leuven | — |
| Completed | De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous NCT01530997 | UNC Lineberger Comprehensive Cancer Center | Phase 2 |
| Completed | Image Guided Adaptive Radiotherapy in the Head-and-neck Region NCT02545322 | Medical University of Graz | N/A |
| Completed | LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent a NCT01345682 | Boehringer Ingelheim | Phase 3 |
| Terminated | Imaging Study for FdCyd and THU Cancer Treatment NCT01479348 | National Cancer Institute (NCI) | EARLY_Phase 1 |
| Completed | A Trial Looking at Treating Dry Mouth After Radiotherapy for Head and Neck Cancer NCT02941276 | University College, London | N/A |
| Terminated | LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck S NCT01345669 | Boehringer Ingelheim | Phase 3 |
| Unknown | RGD-K5 in Head and Neck Cancer Patients NCT01447134 | Chang Gung Memorial Hospital | — |
| Completed | Palliative Radiotherapy Protocol in Head and Neck Cancer NCT02460471 | Maisonneuve-Rosemont Hospital | Phase 2 |
| Terminated | Metformin Plus Paclitaxel for Metastatic or Recurrent Head and Neck Cancer NCT01333852 | Lucas Vieira dos Santos | Phase 2 |
| Unknown | Robot Assisted Supraomohyoid Neck Dissection Via Retroauricular Approach NCT01488669 | Yonsei University | N/A |
| Completed | A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck Cancer NCT01283334 | Emory University | Phase 1 / Phase 2 |
| Unknown | An Efficacy and Safety Study to Assess [18F]-ML-10 in Detecting Response of Tumors to Chemotherapy and Radiati NCT01260480 | Aposense Ltd. | Phase 2 |
| Withdrawn | Pilot Study for Locally Advanced Head and Neck Cancer NCT01262859 | University of Pittsburgh | Phase 2 |
| Terminated | Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer NCT01216020 | Azienda USL 4 Prato | Phase 2 |
| Completed | A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer NCT01087970 | Eli Lilly and Company | Phase 2 |
| Completed | Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma NCT01195922 | National Institute of Dental and Craniofacial Research (NIDCR) | Phase 1 / Phase 2 |
| Withdrawn | Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract NCT01175499 | University of California, San Francisco | N/A |
| Completed | The Fibrosis-Lymphedema Continuum in Head and Neck Cancer NCT01187173 | Vanderbilt University | — |
| Completed | Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Lesions Using Da Vinci Robotic Surgical System NCT01059357 | Wake Forest University Health Sciences | N/A |
| Completed | A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer NCT01057589 | Eli Lilly and Company | Phase 2 |
| Withdrawn | Cetuximab in Combination With Chemotherapy for Patients With Head and Neck Cancer NCT01020864 | Per Pfeiffer | Phase 2 |
| Completed | Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck NCT01065844 | University of Iowa | Phase 2 |
| Unknown | Neoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck Cancer NCT00982436 | University of Vermont | Phase 1 / Phase 2 |
| Completed | DAHANCA 25A: Resistance Training and Dietary Supplements as Intervention for Regaining Muscle Mass Following R NCT01025518 | Danish Head and Neck Cancer Group | N/A |
| Completed | Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registrati NCT00995293 | Sanofi | Phase 3 |
| Completed | A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU) NCT00978250 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Safety Study of Amphinex Based Photochemical Internalisation (PCI) of Bleomycin in Patients With Cutaneous Can NCT00993512 | PCI Biotech AS | Phase 1 |
| Completed | Prognostic Evaluation of 18fmiso Pet-ct in Head and Neck Cancer NCT01235052 | University Hospital, Bordeaux | N/A |
| Completed | A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanc NCT00923481 | National Cancer Institute (NCI) | Phase 2 |
| Completed | A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors NCT00841191 | Centocor, Inc. | Phase 1 / Phase 2 |
| Unknown | The Effect on an Ionic Silver Dressing in Head and Neck Patients With Malignant Fungating Wound NCT00813631 | National Taiwan University Hospital | Phase 4 |
| Completed | Open-Label Trial Of Oral PF-00299804 By Continuous Dosing In Patients With Recurrent Or Metastatic Head And Ne NCT00768664 | Pfizer | Phase 2 |
| Terminated | Postoperative Concurrent Chemoradiation for Head and Neck Cancer With Multiple Minor Risk NCT00937612 | Chang Gung Memorial Hospital | N/A |
| Completed | F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients NCT00721799 | University of Iowa | Phase 2 |
| Unknown | Cisplatin Chemoradiation With or Without Cetuximab for Locoregionally Advanced Squamous Cell Carcinomas (SCC) NCT01301248 | Theagenio Cancer Hospital | Phase 2 |
| Completed | BIBW 2992 (Afatinib) in Head & Neck Cancer NCT00514943 | Boehringer Ingelheim | Phase 2 |
| Unknown | A Pilot Study of the Use of the DaVinci Robotic System for Otorhinolaryngology-Head and Neck Surgery NCT00627562 | Montefiore Medical Center | N/A |
| Terminated | Use of Cone Beam Kilovoltage Imaging in Patients Receiving Radiation Therapy for Head and Neck Cancer NCT00358007 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 2 |
| Completed | C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck NCT00402545 | Dana-Farber Cancer Institute | Phase 1 |
| Completed | A Study for Patients With Head and Neck Cancer NCT00415194 | Eli Lilly and Company | Phase 3 |
| Completed | DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer NCT00400426 | University of Aarhus | Phase 2 |
| Completed | Tumor Hypoxia of Head-and-neck Cancer Underwent Radiation Therapy Measured With F-18-FMISO NCT00180180 | Technische Universität Dresden | — |
| Completed | A Study of ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck NCT00358930 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | Phase 2 |
| Terminated | Oropharyngeal Function After Radiotherapy With IMRT NCT00506324 | Northwestern University | — |
| Unknown | Tranexamic Acid and Head and Neck Surgery Patients NCT00308880 | Taichung Veterans General Hospital | Phase 3 |
| Terminated | Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer NCT00272181 | Sesen Bio, Inc. | Phase 2 |
| Completed | The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer NCT00243347 | AstraZeneca | Phase 1 |
| Terminated | Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and N NCT00412776 | Sesen Bio, Inc. | Phase 2 / Phase 3 |
| Completed | Resistance Exercise Training for the Shoulder and Neck Following Surgery for Head and Neck Cancer NCT00248235 | University of Alberta | Phase 2 / Phase 3 |
| Terminated | Validation of 18F-MISO-PET and 18F-FLT-PET NCT00159978 | Radboud University Medical Center | — |
| Completed | Value of FLT-PET Before and During Radiotherapy in Head and Neck Tumors NCT00163176 | Radboud University Medical Center | — |
| Completed | Does Tranexamic Acid Administration Reduce Blood Loss During Head and Neck Surgery? NCT00147862 | Tata Memorial Hospital | Phase 3 |
| Terminated | Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer NCT00557206 | Minneapolis Veterans Affairs Medical Center | Phase 2 |
| Completed | Efficacy and Activity of BAY 43-9006 in Patients With Recurrent and/or Metastatic Head and Neck Cancer NCT00199160 | Jules Bordet Institute | Phase 2 |
| Completed | Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck NCT00519077 | University of Chicago | Phase 2 |
| Completed | Clinical Trial of New Elastomer for Maxillofacial Prosthetics NCT00123097 | University of Louisville | Phase 3 |
| Completed | S-Frame CT Immobilization Masks For Patients Undergoing Radiation Therapy For Head and Neck Cancer NCT00252473 | University Health Network, Toronto | Phase 2 |
| Completed | Salivary Proteins in Disease and Health NCT00100204 | National Institute of Dental and Craniofacial Research (NIDCR) | — |
| Completed | Efficacy of Chemoradiotherapy After Neoadjuvant Cisplatin and Docetaxel in the Nasopharynx Carcinoma NCT00772681 | Sanofi | Phase 4 |
| Completed | EPO906 Plus Radiation Therapy for the Treatment of Cancer Patients NCT00328458 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 1 |
| Completed | Zalutumumab in Head and Neck Cancer NCT00093041 | Genmab | Phase 1 / Phase 2 |
| Completed | Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma NCT00144976 | Institut Claudius Regaud | N/A |
| Completed | Role of Prophylactic Antibiotics in New Introducer PEG-Gastropexy NCT00375414 | Johann Wolfgang Goethe University Hospital | N/A |
| Terminated | Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Study P02530) NCT00073450 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck Cancer NCT00135161 | University Hospital, Ghent | Phase 1 |
| Completed | Docetaxel in Squamous Cell Carcinoma of the Head and Neck (TAX + Cisplatin in SCCHN) NCT00268671 | Sanofi | Phase 1 / Phase 2 |
| Completed | Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck Cancer NCT00239304 | AstraZeneca | Phase 1 / Phase 2 |
| Completed | The Role of CT-PET-MRI Image Fusion in Determining Radiation Treatment Volumes of Head-and-Neck Cancer Patient NCT00184860 | Radboud University Medical Center | N/A |
| Completed | Neoadjuvant Docetaxel Plus Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy and Ch NCT00357149 | Sanofi | Phase 2 |
| Completed | Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck NCT00057512 | Erimos Pharmaceuticals | Phase 1 |
| Completed | Docetaxel in Head and Neck Cancer NCT00261703 | Sanofi | Phase 2 / Phase 3 |
| Recruiting | Molecular and Genomic Profiling of Head and Neck Tumors NCT00200486 | Montefiore Medical Center | — |
| Completed | Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck Cance NCT00094081 | Sanofi | Phase 3 |
| Completed | Single Dose Escalation Study of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of th NCT02254018 | Boehringer Ingelheim | Phase 1 |
| Completed | NPC Study : TAX + CIS Neoadjuvant in Patients With Loco Regionally Advanced Undifferentiated Carcinoma of Naso NCT00916097 | Sanofi | Phase 2 |
| Completed | Study of Combination Docetaxel and Radiotherapy With or Without Cisplatin to Treat Local Advanced Head and Nec NCT00521521 | Sanofi | Phase 2 |
| Terminated | Patient Evaluation for Head and Neck Surgery Branch Studies NCT00011492 | National Institute on Deafness and Other Communication Disorders (NIDCD) | — |
| Terminated | Porfiromycin Used as an Adjuvant to Radiation Therapy in Postoperative Head and Neck Cancer Patients NCT02183246 | Boehringer Ingelheim | Phase 3 |
| Terminated | Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors NCT02209701 | Boehringer Ingelheim | Phase 1 |
| Completed | Mouth Care Regimes During Radiotherapy NCT00138827 | St George Hospital, Australia | Phase 4 |
| Completed | Dose Escalation Study With 99mTC - or 186 Re-labelled Humanised Monoclonal Antibody (hMAb) BIWA 4 in Patients NCT02204033 | Boehringer Ingelheim | Phase 1 |
| Completed | Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma NCT00401323 | Sanofi | Phase 2 / Phase 3 |
| Withdrawn | Assessment of Head and Neck Tumor Hypoxia Using 18F-Fluoromisonidazole NCT00038038 | M.D. Anderson Cancer Center | N/A |
| Withdrawn | An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotro NCT01747512 | AHS Cancer Control Alberta | Phase 2 |
| Completed | Radiotherapy, Cetuximab, and Injections of TNFerade™ Biologic for Elderly or Frail Patients With Head and Neck NCT00496236 | GenVec | Phase 1 / Phase 2 |
| Available | Expanded Access [11C] Methionine PET Imaging NCT05511714 | St. Jude Children's Research Hospital | — |
| Withdrawn | A Study of Conventional 3D Radiation vs. Intensity-Modulated Radiation in Squamous Cell Cancer of the Head and NCT00363441 | Alberta Health services | Phase 2 / Phase 3 |
| Completed | Phase II Trial of Allovectin-7® for Head and Neck Cancer NCT00050388 | Vical | Phase 3 |
| Completed | A Study of TNFerade™ Biologic With Concomitant Radiotherapy, Fluorouracil, and Hydroxyurea (TNF-FHX) in Patien NCT00496535 | GenVec | Phase 1 / Phase 2 |